For: | Kurimoto N, Inagaki T, Aoki T, Kadotani H, Kurimoto F, Kuriyama K, Yamada N, Ozeki Y. Factors causing a relapse of major depressive disorders following successful electroconvulsive therapy: A retrospective cohort study. World J Psychiatr 2021; 11(10): 841-853 [PMID: 34733646 DOI: 10.5498/wjp.v11.i10.841] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v11/i10/841.htm |
Number | Citing Articles |
1 |
Octavian Vasiliu. Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review. Pharmaceuticals 2023; 16(3): 411 doi: 10.3390/ph16030411
|
2 |
Akise Umakoshi, Masahiro Takeshima, Yu Itoh, Mari Yamamoto, Nana Shibata, Masaya Ogasawara, Naoko Ayabe, Kazuo Mishima. Relationship among psychotic features, benzodiazepine receptor agonists, and rehospitalization in patients with electroconvulsive therapy‐responsive major depressive disorder: A retrospective 2‐year observational study. Neuropsychopharmacology Reports 2022; 42(4): 449 doi: 10.1002/npr2.12282
|